Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-25

Clinical Trial Update: Cannabidiol for Fibromyalgia (The CANNFIB Trial) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating cannabidiol for fibromyalgia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cannabidiol (cannabidiol)

Snippet

Sponsor: Marius Henriksen | Conditions: Fibromyalgia | Phase 3 | Status: COMPLETED